Insider Buying: Takung Art Co Ltd (TKAT) CFO Acquires $135,000.00 in Stock

Takung Art Co Ltd (NYSEAMERICAN:TKAT) CFO Chun Hin Leslie Chow purchased 45,000 shares of the company’s stock in a transaction on Thursday, November 30th. The stock was bought at an average cost of $3.00 per share, for a total transaction of $135,000.00. The transaction was disclosed in a filing with the SEC, which is available through this link.

Chun Hin Leslie Chow also recently made the following trade(s):

  • On Monday, December 4th, Chun Hin Leslie Chow bought 25,000 shares of Takung Art stock. The shares were purchased at an average cost of $3.00 per share, for a total transaction of $75,000.00.

Shares of Takung Art Co Ltd (NYSEAMERICAN TKAT) remained flat at $$2.95 during trading hours on Thursday. 200 shares of the company’s stock were exchanged, compared to its average volume of 3,619. Takung Art Co Ltd has a 1 year low of $2.15 and a 1 year high of $10.50.

ILLEGAL ACTIVITY WARNING: “Insider Buying: Takung Art Co Ltd (TKAT) CFO Acquires $135,000.00 in Stock” was originally published by Stock Observer and is owned by of Stock Observer. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.thestockobserver.com/2017/12/07/insider-buying-takung-art-co-ltd-tkat-cfo-acquires-135000-00-in-stock.html.

About Takung Art

Takung Art Co, Ltd., formerly Cardigant Medical Inc, is a holding company. The Company, through HongKong Takung Assets and Equity of Artworks Exchange Co, Ltd. (HongKong Takung), and its subsidiaries, operates an electronic online platform located at www.takungae.com for artists, art dealers and art investors to offer and trade in artwork.

Receive News & Ratings for Takung Art Co Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takung Art Co Ltd and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply